Clinical Trial Finder

Inclusion Criteria:

1. Patients diagnosed with erosive hand OA, non-erosive hand OA, or first carpometacarpal joint OA with a Kellgren- Lawrence grade >1 as determined by radiographic assessments and the American College of Rheumatology (ACR) classification. 2. Patients age 40-75. 3. Patients who are willing and able to adhere to follow-up schedule and protocol guidelines. 4. Patients who are willing and able to sign corresponding research subject consent form.

Exclusion Criteria:

1. Patient has a history of neurological conditions, including multiple sclerosis or Parkinson's disease. 2. Patient has had prior surgical treatment of the hands in the last 5 years or injection treatment in the last 6 months. 3. Patient has secondary OA including causes such as gout, rheumatoid arthritis, psoriatic arthritis. 4. Patient has used topical creams or gels for arthritic pain including nonsteroidal anti-inflammatory drugs, capsaicin, lidocaine, or counterirritants in the last 1 week. 5. Patient has a history of carpal tunnel syndrome, cubital tunnel syndrome, or radial tunnel syndrome. 6. Patient has a history of peripheral neuropathy. 7. Patient has chronic pain conditions unrelated to hand condition. 8. Patient has auto-immune or auto-inflammatory diseases. 9. Patient has used tobacco within the last 90 days. 10. Patient is not within the ages of 40-75. 11. Patient has an active infection (local or systemic) 12. Patient is unwilling or unable to sign the corresponding research subject consent form. 13. Patient meets any other criteria or has any other condition that, in the opinion of the investigator, would prevent them from completing the study or that, in the opinion of the investigator, would confound study results. -

Exclusion Criteria:

-

The semiconductor embedded fabric emits mid-level and far infrared waves and negative ions to the tissue which can increase circulation of both blood and lymph, plus facilitates the anti-inflammatory nitric oxide cascade by accelerating the binding of Calcium to Calmodulin. Nitric oxide down-regulates interleukin1 beta and inducible nitric oxide synthase in certain cell types, which leads to reduced cyclooxygenase-2 and prostaglandins-molecules responsible for causing inflammation and pain. Unlike other systemic COX-2 inhibitors such as nonsteroidal anti-inflammatory drugs (NSAIDs), targeted infrared and negative ion therapy stimulate localized reaction pathways, thereby reducing pain and inflammation. This study seeks to identify patient reported subjective and clinically measured objective outcomes for hand osteoarthritis pain management and hand function with application of semiconductor embedded fabric in the affected area.

Arms

Active Comparator: Semiconductor circulation gloves

The gloves will have semiconductors embedded in the fabric.

Placebo Comparator: Placebo circulation gloves

The gloves will look identical to the active circulation gloves, but will not have semiconductors embedded into the fabric

Interventions

Device: - Non-invasive circulation gloves

Non-invasive class I medical device, circulation gloves with semiconductors embedded in the fabric.

Device: - Fabric gloves

These gloves will look and feel identical to the active circulation gloves, but will not have semiconductors embedded in the fabric.